Myriad Genetics (MYGN) Goodwill & Intangibles (2010 - 2026)

Myriad Genetics (MYGN) has 17 years of Goodwill & Intangibles data on file, last reported at $192.8 million in Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $192.8 million, down 64.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $192.8 million (down 64.55% YoY), and the FY2025 annual result was $205.0 million, down 62.64% from the prior year.
• Goodwill & Intangibles declined to $192.8 million in Q1 2026 per MYGN's latest filing, from $205.0 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $666.5 million in Q4 2022 and troughed at $192.8 million in Q1 2026.
• A 5-year average of $521.7 million and a median of $607.3 million in 2022 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2023 and 2026: Goodwill & Intangibles increased 5.91% in 2023, then tumbled 64.55% in 2026.
• A 5-year view of Goodwill & Intangibles shows it stood at $666.5 million in 2022, then declined by 4.44% to $636.9 million in 2023, then decreased by 13.85% to $548.7 million in 2024, then tumbled by 62.64% to $205.0 million in 2025, then decreased by 5.95% to $192.8 million in 2026.
• Business Quant data shows MYGN's Goodwill & Intangibles at $192.8 million in Q1 2026, $205.0 million in Q4 2025, and $214.7 million in Q3 2025.